Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis

Nephrol Dial Transplant. 2022 Mar 25;37(4):789-791. doi: 10.1093/ndt/gfab323.

Authors

Affiliations

¹ Nephrology, Dialysis and Transplant Unit, Careggi University Hospital, Florence, Italy.
² Nephrology Unit, Meyer Children's Hospital and Department of Biomedical Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.

PMID: 34788862
DOI: 10.1093/ndt/gfab323

No abstract available

MeSH terms

Adult
Female
Glomerulosclerosis, Focal Segmental* / complications
Glomerulosclerosis, Focal Segmental* / drug therapy
Humans
Kidney Transplantation*
Male
Nephrosis, Lipoid* / drug therapy
Proteinuria / drug therapy
Proteinuria / etiology
Recurrence
Rituximab / therapeutic use

Substances

Rituximab